Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066821

President and CEO gave up 1,811 shares (to pay taxes)

  • President and CEO acquired 5,958 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-12-15 Exercise or conversion : show line 1 in the form +3,033 877,052 D
2017-12-15 Shares withheld for taxes : show line 2 in the form −922 $24.23 $22,340 876,130 D
2017-12-18 Exercise or conversion : show line 3 in the form +2,925 879,055 D
2017-12-18 Shares withheld for taxes : show line 4 in the form −889 $24.12 $21,443 878,166 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-12-15 Exercise or conversion : show line 5 in the form Restricted Stock Units −3,033 21,233 D
2017-12-18 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,925 5,850 D
Loading xslF345X03/doc4.xml…